The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III trial to evaluate omentum preserving gastrectomy for patients with resectable advanced gastric cancer: JCOG1711 (ROAD-GC).
 
Takanobu Yamada
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology
Research Funding - Lilly
 
Yuya Sato
No Relationships to Disclose
 
Ryunosuke Machida
No Relationships to Disclose
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Hiroshi Katayama
No Relationships to Disclose
 
Masanori Tokunaga
No Relationships to Disclose
 
Yasunori Nishida
No Relationships to Disclose
 
Jun Hihara
No Relationships to Disclose
 
Masaya Watanabe
No Relationships to Disclose
 
Yasuhiro Choda
No Relationships to Disclose
 
Souya Nunobe
No Relationships to Disclose
 
Junya Fujita
No Relationships to Disclose
 
Masahide Kaji
No Relationships to Disclose
 
Norimasa Fukushima
No Relationships to Disclose
 
Seiji Ito
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca
Research Funding - Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)